Skin TransplantationOrgan TransplantationTransplantation, HomologousGraft RejectionLiver TransplantationGraft SurvivalKidney TransplantationHeart TransplantationBone Marrow TransplantationLung TransplantationHematopoietic Stem Cell TransplantationTransplantationTransplantation ImmunologyTissue DonorsTransplantation, AutologousImmunosuppressive AgentsMice, Inbred BALB CTissue and Organ ProcurementMice, Inbred C57BLPancreas TransplantationStem Cell TransplantationTransplantation ConditioningTransplantation ToleranceImmunosuppressionIslets of Langerhans TransplantationTransplantation ChimeraSkinHeart-Lung TransplantationCell TransplantationTransplantsLiving DonorsTreatment OutcomeTacrolimusRetrospective StudiesBrain DeathTransplantation, HeterotopicTransplantation, IsogeneicGraft vs Host DiseaseCyclosporineTime FactorsWaiting ListsPostoperative ComplicationsHistocompatibility TestingCadaverCord Blood Stem Cell TransplantationTransplantation, HeterologousLiver FailureOrgan PreservationFollow-Up StudiesLymphoproliferative DisordersSurvival RateSkin NeoplasmsSurvival AnalysisTissue TransplantationPeripheral Blood Stem Cell TransplantationRecurrenceCorneal TransplantationFetal Tissue TransplantationHistocompatibilityDonor SelectionMycophenolic AcidRisk FactorsCytomegalovirus InfectionsSkin DiseasesTissue and Organ HarvestingAntilymphocyte SerumPrognosisHLA AntigensMesenchymal Stem Cell TransplantationHematologic NeoplasmsLiver DiseasesSkin AgingRats, Inbred LewMedical TourismWhole-Body IrradiationProspective StudiesCombined Modality TherapyT-LymphocytesChimerismImmune ToleranceAzathioprineIsoantibodiesImmunocompromised HostPatient SelectionKidney Failure, ChronicEarly Detection of CancerBiopsyOrgan Preservation SolutionsLiverNeoplasmsFatal OutcomeBrain Tissue TransplantationNeoplasm TransplantationIncidenceAntibodies, MonoclonalBlood Group IncompatibilityFacial TransplantationDisease-Free SurvivalHost vs Graft ReactionPostoperative Period